Oragenics Inc.

09/20/2024 | Press release | Distributed by Public on 09/20/2024 14:11

Proxy Statement Form 8 K

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) Compensatory Arrangements of Certain Officers.

Executive Officer Stock Option Awards. On September 19, 2024, the Compensation Committee and Board of Directors approved an award of stock options (the "Options") to certain of our executive officers under the Company's 2021 Equity Incentive Plan, as amended (the "Plan"), consisting of 100,000 shares to J. Michael Redmond, our President, and 80,000 shares to Janet Huffman, our Chief Financial Officer. The Options vest immediately. The Options are subject to the terms and conditions of the Plan and the Company's form of option award agreement.